Risk of teratoma formation after transplantation of induced pluripotent stem cells

Chest

Volumn 141, Issue 4, 2012, Pages 1120-1121

  Masuda, Shigeo ^a,b,c  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ACUTE LUNG INJURY; ALLOTRANSPLANTATION; CANCER RISK; CELL DIFFERENTIATION; GENE OVEREXPRESSION; GRAFT REJECTION; IMMUNOGENICITY; LETTER; NONHUMAN; OUTCOME ASSESSMENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION; TERATOMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 84859508502     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2790     Document Type: Letter

References (4)

1. Yang K-Y, Shih H-C, How C-K, et al. IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest. 2011;140(5):1243-1253.
2. Masuda S, Hanazono Y. Induced pluripotent stem cells in long-QT syndrome. N Engl J Med. 2011;364(2):181-182.
3. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350):212-215.
4. Okita K, Nagata N, Yamanaka S. Immunogenicity of induced pluripotent stem cells. Circ Res. 2011;109(7):720-721.